Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

As a small business owner, Liz understands the unique challenges entrepreneurs face. Well-versed in the digital landscape, she combines real-world experience in website design, building e-commerce ...

Don't let the multitude of web hosting options overwhelm your site-building journey. We help you narrow your search with these top, tested services. My career has taken me through an eclectic ...

The company says its ADC platform is designed to balance safety and efficacy for each target, and is already attracting interest from big pharma partners. The Series A financing was led by Brandon ...

Join these multi-day events at no cost to accelerate your adoption of Power Platform and Copilot Studio (including ... end-to-end low-code solution in minutes. We are excited to announce that SQL ...